Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
All posts by David Emerson
Multiple Myeloma – First Line Treatment
First-line treatment (sometimes referred to as induction therapy, primary therapy, or front-line therapy) is the first therapy that will be tried for all newly diagnosed myeloma patients. A breakthrough
Continue readingMultiple Myeloma – Stage 3
“For the first time ever, (in 2010) a three-drug regimen resulted in a 100% response rate and a favorable tolerability profile in patients with multiple myeloma, according to new findings…” Multiple
Continue readingMyeloma, stage 3 young…
“In newly diagnosed patients treated with induction, stem cell transplantation, and Revlimid maintenance therapy, the proportion of patients who get to a complete response is approximately 30% Hi
Continue readingSCT Secondary Cancer
“We describe baseline incidence and risk factors for new cancers (treatment-related secondary cancer) in 4161 persons receiving autotransplants for multiple myeloma in the United States from 1990
Continue readingMultiple Myeloma – Stage 2
According to one study, more than half of those diagnosed with multiple myeloma in stage 2 live 7 years or more past the start of treatment. According to research, more than 95% of all newly diagnosed
Continue readingNewly Diagnosed Multiple Myeloma – Stage 1
It is critical for the myeloma – stage 1 patient to understand that he/she is an outlier, statistically speaking, when compared to the “average” newly diagnosed patient. Newly diagnosed
Continue readingStage 1 Multiple Myeloma Treatment- NOT SOC!
“However, hematopoietic stem cell transplantation (HSCT) survivors are at risk of developing long-term complications, such as endocrinopathies, musculoskeletal disorders, cardiopulmonary compromise
Continue readingStage 1 Myeloma, Kidney Disease?
My question is can a stage 1 patient survive very long with your bone marrow biopsy indicating monoclonal proteins of 7-10 percent? Hi David- Stage 1 myeloma– I am 71 years old and was diagnosed
Continue readingMultiple Myeloma – Alternative Therapy
Gerson, Poly MVA, CHIPSA, Insulin Potentiation Therapy, Laetrile, etc. etc.- I have studied alternative therapies for multiple myeloma for years and never found credible evidence of success- The first
Continue readingVelcade/Bortezomib- CIPN, Heart, Blood, Muscle Damage
“Although peripheral neuropathy and myelosuppression have been recognized as the most relevant bortezomib-related adverse effects, cardiac and skeletal muscle toxicities are relatively common in
Continue reading